LifeStance Health Group (NASDAQ:LFST) Stock Price Expected to Rise, KeyCorp Analyst Says

LifeStance Health Group (NASDAQ:LFST) had its price target upped by equities researchers at KeyCorp from $15.00 to $17.00 in a research note issued to investors on Friday, Benzinga reports. The brokerage currently has an “overweight” rating on the stock. KeyCorp‘s target price would suggest a potential upside of 23.46% from the stock’s current price.

LFST has been the topic of several other reports. BTIG Research lifted their price target on shares of LifeStance Health Group from $18.00 to $20.00 and gave the company a “buy” rating in a research note on Thursday. Zacks Research cut LifeStance Health Group from a “strong-buy” rating to a “hold” rating in a report on Monday, July 13th. Wall Street Zen lowered LifeStance Health Group from a “strong-buy” rating to a “buy” rating in a report on Saturday, September 5th. Weiss Ratings raised LifeStance Health Group from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, August 11th. Finally, Canaccord Genuity Group raised their price target on LifeStance Health Group from $13.00 to $15.00 and gave the company a “buy” rating in a research note on Wednesday, September 9th. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, LifeStance Health Group presently has a consensus rating of “Moderate Buy” and a consensus target price of $13.75.

LifeStance Health Group Trading Up 2.5%

NASDAQ LFST opened at $13.77 on Friday. The stock has a 50-day simple moving average of $12.62 and a 200 day simple moving average of $9.49. The company has a market capitalization of $5.26 billion, a PE ratio of 72.48 and a beta of 1.35. The company has a current ratio of 1.44, a quick ratio of 1.38 and a debt-to-equity ratio of 0.17. LifeStance Health Group has a 12 month low of $5.87 and a 12 month high of $15.66.

LifeStance Health Group (NASDAQ:LFST) last announced its quarterly earnings results on Thursday, November 5th. The company reported $0.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.04 by $0.02. LifeStance Health Group had a net margin of 4.29% and a return on equity of 4.82%. The company had revenue of $455.86 million during the quarter, compared to analyst estimates of $431.59 million. The company’s revenue for the quarter was up 25.3% compared to the same quarter last year. Research analysts forecast that LifeStance Health Group will post 0.17 EPS for the current year.

Insider Buying and Selling at LifeStance Health Group

In related news, major shareholder Tpg Gp A, Llc sold 13,643,207 shares of the firm’s stock in a transaction on Monday, August 10th. The stock was sold at an average price of $10.62, for a total transaction of $144,890,858.34. Following the completion of the transaction, the insider directly owned 98,101,407 shares of the company’s stock, valued at $1,041,836,942.34. This trade represents a 12.21% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CTO Vukasin Paunovich sold 42,067 shares of the firm’s stock in a transaction dated Wednesday, September 2nd. The stock was sold at an average price of $12.87, for a total value of $541,402.29. Following the transaction, the chief technology officer owned 205,379 shares of the company’s stock, valued at $2,643,227.73. This trade represents a 17.00% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 13,777,580 shares of company stock worth $146,433,781 over the last quarter. Corporate insiders own 3.50% of the company’s stock.

Institutional Trading of LifeStance Health Group

Hedge funds have recently bought and sold shares of the business. Diversified Trust Co increased its stake in shares of LifeStance Health Group by 5.7% in the third quarter. Diversified Trust Co now owns 78,109 shares of the company’s stock worth $940,000 after buying an additional 4,189 shares during the period. Fifth Third Bancorp raised its holdings in LifeStance Health Group by 10.7% during the 3rd quarter. Fifth Third Bancorp now owns 180,736 shares of the company’s stock valued at $2,174,000 after buying an additional 17,414 shares during the last quarter. Maryland State Retirement & Pension System boosted its position in LifeStance Health Group by 80.5% during the 3rd quarter. Maryland State Retirement & Pension System now owns 60,294 shares of the company’s stock valued at $725,000 after buying an additional 26,896 shares during the period. Summit Creek Advisors LLC purchased a new stake in LifeStance Health Group during the 3rd quarter valued at $2,408,000. Finally, StoneX Group Inc. purchased a new stake in LifeStance Health Group during the 3rd quarter valued at $132,000. Institutional investors and hedge funds own 85.50% of the company’s stock.

LifeStance Health Group News Summary

Here are the key news stories impacting LifeStance Health Group this week:

• Positive Sentiment: LifeStance reported Q3 adjusted earnings of $0.06 per share, ahead of estimates, and revenue of $455.9 million versus forecasts of about $431.6 million. Revenue grew 25.3% year over year, and the company raised its full-year outlook—evidence of stronger-than-expected performance. LifeStance Q3 results and outlook
• Positive Sentiment: Analysts raised their targets and maintained bullish ratings: KeyCorp lifted its target to $17 with an “overweight” rating, Canaccord Genuity raised its target to $16 with a “buy” rating, and BTIG increased its target to $20, also with a “buy” rating. These revisions signal greater optimism about potential upside. KeyCorp rating Canaccord Genuity rating BTIG target increase
• Neutral Sentiment: Coverage noted LFST reached a 52-week high and highlighted its momentum, though those signals alone do not establish whether further gains are sustainable. Zacks coverage of LFST’s high

LifeStance Health Group Company Profile

LifeStance Health Group, Inc is a provider of outpatient behavioral health services in the United States. Through a network of clinicians and care centers, the company offers mental health care through in-person appointments and telehealth visits.

LifeStance’s services include individual, couples and family therapy; psychiatric evaluation and medication management; psychological and neuropsychological testing; and treatment for conditions such as depression, anxiety, attention-deficit/hyperactivity disorder, bipolar disorder, post-traumatic stress disorder and other behavioral health concerns.